NM_013352.4:c.1926T>C
Variant names:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_013352.4(DSE):c.1926T>C(p.Asn642Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.938 in 1,614,096 control chromosomes in the GnomAD database, including 710,142 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.96 ( 69521 hom., cov: 30)
Exomes 𝑓: 0.94 ( 640621 hom. )
Consequence
DSE
NM_013352.4 synonymous
NM_013352.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0270
Genes affected
DSE (HGNC:21144): (dermatan sulfate epimerase) The protein encoded by this gene is a tumor-rejection antigen. It is localized to the endoplasmic reticulum and functions to convert D-glucuronic acid to L-iduronic acid during the biosynthesis of dermatan sulfate. This antigen possesses tumor epitopes capable of inducing HLA-A24-restricted and tumor-specific cytotoxic T lymphocytes in cancer patients and may be useful for specific immunotherapy. Mutations in this gene cause inmusculocontractural Ehlers-Danlos syndrome. Alternative splicing results in multiple transcript variants. A related pseudogene has been identified on chromosome 9, and a paralogous gene exists on chromosome 18. [provided by RefSeq, Apr 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.64).
BP6
Variant 6-116436394-T-C is Benign according to our data. Variant chr6-116436394-T-C is described in ClinVar as [Benign]. Clinvar id is 1166942.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-116436394-T-C is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-0.027 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.98 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DSE | ENST00000644252.3 | c.1926T>C | p.Asn642Asn | synonymous_variant | Exon 6 of 6 | NM_013352.4 | ENSP00000494147.2 | |||
ENSG00000285446 | ENST00000644499.1 | c.766+5201T>C | intron_variant | Intron 3 of 3 | ENSP00000495266.1 |
Frequencies
GnomAD3 genomes AF: 0.955 AC: 145283AN: 152108Hom.: 69461 Cov.: 30
GnomAD3 genomes
AF:
AC:
145283
AN:
152108
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.954 AC: 239609AN: 251204Hom.: 114364 AF XY: 0.953 AC XY: 129442AN XY: 135756
GnomAD3 exomes
AF:
AC:
239609
AN:
251204
Hom.:
AF XY:
AC XY:
129442
AN XY:
135756
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.936 AC: 1368178AN: 1461870Hom.: 640621 Cov.: 94 AF XY: 0.937 AC XY: 681353AN XY: 727240
GnomAD4 exome
AF:
AC:
1368178
AN:
1461870
Hom.:
Cov.:
94
AF XY:
AC XY:
681353
AN XY:
727240
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.955 AC: 145402AN: 152226Hom.: 69521 Cov.: 30 AF XY: 0.958 AC XY: 71277AN XY: 74414
GnomAD4 genome
AF:
AC:
145402
AN:
152226
Hom.:
Cov.:
30
AF XY:
AC XY:
71277
AN XY:
74414
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3440
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Ehlers-Danlos syndrome, musculocontractural type 2 Benign:2
Jul 30, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at